Pancreatic Cancer Treatment Market Regional Analysis, Competitive Landscape and Forecast to 2027

 

Pancreatic Cancer Market Overview

Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global pancreatic cancer market, as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period (2017-2023).

The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging demand for targeted therapy is considered another propelling factor for the pancreatic cancer therapy market. Targeted therapy aims specific receptors present in the cancerous cells and does not harm the healthy peripheral cells compared to conventional methods such as chemotherapy.

With changing lifestyle, the consumption of tobacco has increased. Also, there has been a surging rate of cigarette smoking, which is likely to enhance the pancreatic cancer market. Moreover, rising intake of alcohol, surging rates of obesity, and rising awareness about several treatment options available in the market are likely to encourage the market growth in the foreseeable future.

On the contrary, costly treatment, coupled with the side effects associated with the treatment of such diseases, are predicted to restrict the market growth.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/reports/pancreatic-cancer-market-1638

Global Pancreatic Cancer Market: Segmental Analysis

The pancreatic cancer market has been segmented on the basis of treatment, types, and end user.

By type, the pancreatic cancer market is segmented into exocrine pancreas cancer, endocrine pancreas cancer, and others.





The treatment segment includes surgery & radiation therapy, chemotherapy, biologic therapy, targeted therapy, hormone therapy, and others. Of these, the targeted therapy segment is estimated to gain prominence due to the surging demand for this treatment method.

The end users segment comprises research institute, hospitals & clinics, and others. Of these, the hospitals & clinics segment is predicted to register a significant share due to the availability of advanced treatment facilities and favorable reimbursement policies.

Regional Frontiers

Geographically, the pancreatic cancer market spans across Europe, America, Asia Pacific, and the Middle East & Africa.

The pancreatic cancer market is likely to be dominated by America, mainly due to the presence of well-developed technology, increased healthcare spending, rising prevalence of cancer patients, and soaring support from the government for research and development activities. The presence of industry bigshots in the region has further propelled the market growth.

Europe acquires the second position globally and is likely to retain its growth in the coming years due to increased support from the government for research and development activities. The high availability of funds for research will further contribute to the market growth in the region. Countries like France and Germany are highly investing in the healthcare segment, which has created new growth opportunities for the market.

The Asia Pacific will register the fastest growth rate due to the existence of rapidly evolving healthcare technology, increased expenditure on healthcare, and surging patient population. Soaring demand for latest treatment methods in countries like South Korea and India will influence the regional market’s growth.

Competitive Dashboard

The top players operating in the pancreatic cancer market include OncoGenex Pharmaceuticals Inc. (U.S.), Pharmacyte Biotech Inc. (U.S.), Diffusion Pharmaceuticals (U.S.), Oncolytics Biotech (Canada), Sun BioPharma, Inc. (U.S.), Polaris Pharmaceuticals, Inc. (U.S.), Clovis Oncology (U.S.), Eli Lilly and Company (U.S.), Midatech Pharma PLC (U.K.), F. Hoffmann-La Roche AG (Switzerland), Celgene Corporation (U.S.), Novartis International AG (U.S.), Amgen, Inc. (U.S.), and others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/pancreatic-cancer-market-1638

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

 

 

Comments

Post a Comment

Popular posts from this blog

Asthma Inhaler Device market poised to achieve significant growth in the years to come

  Asthma Inhaler Device Market Overview The global asthma inhaler devices market is likely to expand at 5.2 % CAGR during the forecast period (2017-2022) owing to the increasing prevalence of asthma among the crowd, asserts Market Research Future (MRFR). An inflammatory disease of the lungs, asthma is characterized by the difficulty faced while breathing. The symptoms of asthma are often triggered with exposure to allergens such as ragweed, pollen, animal dander, and irritants such as chemical fumes and smoke. Asthma leads to swelling of the inside walls of an asthmatic’s airways and makes airways sensitive to irritations. Drivers and Constraints Impacting the Market With the increasing prevalence of asthma especially among the children, the market is likely to propel over the assessment period. For instance, around 9 million children under five years of age die every year due to the presence of lung diseases. The increasing disposable income and rising preference for combinati...
Read more

Surgical Drapes and Gowns Market Trends with worldwide Industry Analysis, Features, Top Player and Forecast 2030

Image
  Surgical Drapes and Gowns Market Overview The Global Surgical Drapes and Gowns anticipated to have held a market value of USD 2.23 billion in the year 2017 and is expected to grow at a CAGR of 4.4% during the forecast period. Surgical drapes and surgical gowns are used during surgery to maintain sterile surgical field and reduce the risk of contamination and prevention of surgical site infection. Surgical drapes and surgical gowns are used by patients and healthcare professional such as, nurses and doctors. Hospitals, clinics and ambulatory surgical centers are the major end user of the surgical drapes and surgical gowns products. Similarly, According to Public Health England, during 2016 to 2017 around 139,691 procedures were performed in NHS based hospitals in England and about 1,635 surgical site infections (SSIs) detected during the same period. Increasing number of surgeries in healthcare settings and high incidences of hospital-acquired infections are expec...
Read more

Blood Grouping Reagents Market is Expected to Grow at a CAGR of 7.74% by 2027

  Blood Grouping Reagents Market Overview The global blood grouping reagents market is expected to register a CAGR of   7.74%  during the forecast period and is expected to hit USD 2,642.17 million by 2027. Blood grouping reagents are solutions that can be used to determine ABO, Rhesus, Kell and MNS blood groups These classifications of human blood are all based on the presence or absence of certain antigens on the surface of red blood cells. The growth of the global blood grouping reagents market is expected to be driven by increasing prevalence of chronic disorders, increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hamper the growth of this market. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10725 Segment Analysis The global blood grouping reagents market is mainly segmented into product, technique, and test type, end user. On the basis of product, the blood groupin...
Read more